Article
Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness…
medRxiv: the preprint server for health sciences · 2023 · Christina E. Hoeve, author Brechje de Gier, author Anne J. Huiberts, author Hester E. de Melker, author Susan J.M. Hahné, author Susan van den Hof, author Mirjam J. Knol, author
Key facts
| Title | Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022 |
|---|---|
| First author | Christina E. Hoeve, author Brechje de Gier, author Anne J. Huiberts, author Hester E. de Melker, author Susan J.M. Hahné, author Susan van den Hof, author Mirjam J. Knol, author |
| Journal | medRxiv : the preprint server for health sciences |
| Published | Jan 13, 2023 |
| DOI | 10.1101/2023.01.10.23284386 |
| Devices mentioned | BK230839, BK230840, K000042, K000155, K000270, K000534, K000576, K001014, K001015, K001468, K001846, K001906 and 222 more |
| Product codes mentioned | CDD, CDP, CDS, CDX, CDZ, CEC, CEM, CEP, CEW, CFL, CFP, CFT and 99 more |
At a glance
- 100–999 FDA submissions mentioned
- 100–999 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1